EX-23.1 2 v374179_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 20, 2014 with respect to the financial statements  included in the Annual Report on Form 10-K for the year ended December 31, 2013 of Interleukin Genetics, Inc., which are contained in this Registration Statement and Prospectus.  We consent to inclusion in the Registration Statement and Prospectus of the aforementioned reports, and to the use of our name as it appears under the caption "Experts.”

 
/s/ GRANT THORNTON LLP
 
Boston, Massachusetts
May 16, 2014